Home/Filings/4/0001493152-24-003447
4//SEC Filing

Newman Michael James 4

Accession 0001493152-24-003447

CIK 0001857044other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 4:15 PM ET

Size

5.7 KB

Accession

0001493152-24-003447

Insider Transaction Report

Form 4
Period: 2024-01-22
Newman Michael James
DirectorCSO and Director10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-01-22+43,25043,250 total
    Exercise: $1.74Exp: 2034-01-22Common Stock (43,250 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable as to one-third of the total shares on January 22, 2025 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 22, 2027.

Documents

1 file

Issuer

Indaptus Therapeutics, Inc.

CIK 0001857044

Entity typeother

Related Parties

1
  • filerCIK 0001876315

Filing Metadata

Form type
4
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 4:15 PM ET
Size
5.7 KB